Open Label Study of GSK2402968 in Subjects With Duchenne Muscular Dystrophy

Clinical trial NCT01480245 · TERMINATED

Trial details

NCT number: NCT01480245
Sponsor: GlaxoSmithKline
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Muscular Dystrophies

Start date: 2011-09-01
Primary completion: 2014-03-01
Enrollment: 233

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.